Neo-Antigens Websites
Epivax Oncology | Precision Medicine | United States
EpiVax Oncology, a precision cancer immunotherapy company, is developing mutanome-directed, neo-epitope personalized therapeutic vaccines. EpiVax Oncology’s therapeutic vaccines are customized and specifically designed for each patient’s tumors, leveraging advances in next generation immunology.
Not Applicable
$
8.95
